Akanda Corp. (AKAN)

USD 1.2

(7.14%)

Gross Profit Summary of Akanda Corp.

  • Akanda Corp.'s latest annual gross profit in 2023 was 111.44 Thousand USD , down -426.32% from previous year.
  • Akanda Corp.'s latest quarterly gross profit in 2024 Q2 was -139.24 Thousand USD , down 0.0% from previous quarter.
  • Akanda Corp. reported a annual gross profit of 1.96 Million USD in annual gross profit 2022, up 375.6% from previous year.
  • Akanda Corp. reported a annual gross profit of -714.72 Thousand USD in annual gross profit 2021, down -282600.4% from previous year.
  • Akanda Corp. reported a quarterly gross profit of -2.76 Million USD for 2023 Q2, down -691.21% from previous quarter.
  • Akanda Corp. reported a quarterly gross profit of -411.98 Thousand USD for 2023 Q3, up 85.1% from previous quarter.

Annual Gross Profit Chart of Akanda Corp. (2023 - 2019)

Historical Annual Gross Profit of Akanda Corp. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 111.44 Thousand USD -426.32%
2022 1.96 Million USD 375.6%
2021 -714.72 Thousand USD -282600.4%
2020 253.00 USD 100.13%
2019 -198.82 Thousand USD 0.0%

Peer Gross Profit Comparison of Akanda Corp.

Name Gross Profit Gross Profit Difference
Intra-Cellular Therapies, Inc. 430.62 Million USD 99.974%
PainReform Ltd. -15 Thousand USD 842.993%
Alvotech -69.42 Million USD 100.161%
Collegium Pharmaceutical, Inc. 326.16 Million USD 99.966%
ANI Pharmaceuticals, Inc. 305.3 Million USD 99.963%
Aquestive Therapeutics, Inc. 29.75 Million USD 99.625%
Journey Medical Corporation 52.52 Million USD 99.788%
Dynavax Technologies Corporation 182.11 Million USD 99.939%
Esperion Therapeutics, Inc. 73.06 Million USD 99.847%
Bright Green Corporation -237.01 Thousand USD 147.022%
Pacira BioSciences, Inc. 490.3 Million USD 99.977%
Embecta Corp. 749.9 Million USD 99.985%
Sunshine Biopharma, Inc. 8.33 Million USD 98.664%
Sunshine Biopharma, Inc. 8.33 Million USD 98.664%
SCYNEXIS, Inc. 124.51 Million USD 99.91%
Petros Pharmaceuticals, Inc. 4.19 Million USD 97.341%
Silver Spike Investment Corp. 8.1 Million USD 98.625%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD 79.882%
Alpha Teknova, Inc. 10.29 Million USD 98.918%
Safety Shot Inc -74.45 Thousand USD 249.682%
Procaps Group, S.A. 239.56 Million USD 99.953%
Cosmos Health Inc. 4.34 Million USD 97.438%
Theratechnologies Inc. 62.12 Million USD 99.821%
Harrow Health, Inc. 90.55 Million USD 99.877%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD 97.651%
Biofrontera Inc. 16.62 Million USD 99.33%
DURECT Corporation 6.83 Million USD 98.368%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 99.979%
Cronos Group Inc. 6.99 Million USD 98.406%
OptiNose, Inc. 62.35 Million USD 99.821%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 99.975%
Kala Pharmaceuticals, Inc. -303 Thousand USD 136.782%
RedHill Biopharma Ltd. 3.05 Million USD 96.351%
Organogenesis Holdings Inc. 309.79 Million USD 99.964%
Guardion Health Sciences, Inc. 5.39 Million USD 97.934%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 99.667%
Radius Health, Inc. 307.71 Million USD 99.964%
Universe Pharmaceuticals INC 10.07 Million USD 98.894%
ProPhase Labs, Inc. 16.23 Million USD 99.314%
Phibro Animal Health Corporation 312.48 Million USD 99.964%
Procaps Group S.A. 239.56 Million USD 99.953%
TherapeuticsMD, Inc. 1.3 Million USD 91.44%
Viatris Inc. 6.43 Billion USD 99.998%
Rockwell Medical, Inc. 8.7 Million USD 98.72%
Aytu BioPharma, Inc. 54.58 Million USD 99.796%
SIGA Technologies, Inc. 122.09 Million USD 99.909%
Tilray Brands, Inc. 223.35 Million USD 99.95%
Lifecore Biomedical, Inc. 41.85 Million USD 99.734%
Shineco, Inc. 882.16 Thousand USD 87.366%
PetIQ, Inc. 252.74 Million USD 99.956%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 114.948%
Incannex Healthcare Limited 12 Thousand USD -828.742%
Neurocrine Biosciences, Inc. 1.84 Billion USD 99.994%
Alimera Sciences, Inc. 61.17 Million USD 99.818%
Assertio Holdings, Inc. 125.04 Million USD 99.911%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 1736.309%
Clever Leaves Holdings Inc. 6.55 Million USD 98.3%
Cyclo Therapeutics, Inc. -2.41 Million USD 104.624%
Avadel Pharmaceuticals plc 27.11 Million USD 99.589%
Hempacco Co., Inc. -1.21 Million USD 109.166%
Talphera, Inc. -4.89 Million USD 102.277%
Alvotech -69.42 Million USD 100.161%
Eagle Pharmaceuticals, Inc. 221.67 Million USD 99.95%
Lantheus Holdings, Inc. 709.54 Million USD 99.984%
Currenc Group, Inc. 17.35 Million USD 99.358%
Kamada Ltd. 52.59 Million USD 99.788%
Indivior PLC 907 Million USD 99.988%
Evoke Pharma, Inc. 4.97 Million USD 97.762%
Flora Growth Corp. 17.73 Million USD 99.372%
Cyclo Therapeutics, Inc. -2.41 Million USD 104.624%
Evolus, Inc. 140.52 Million USD 99.921%
HUTCHMED (China) Limited 453.55 Million USD 99.975%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 99.968%